CD40 and pancreatic neoplasm: Nevertheless, CD40 agonists given as a single modality have shown beneficial effect also in human clinical trials with PDAC patients13, 14, 27 and our previous studies have demonstrated that upon IL‐15 stimulation, human NK cells can kill both pancreatic cancer and stromal stellate cells in an autologous human ex vivo setting.18